Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?

Key Takeaways ISRG delivered 22% pro forma EPS growth in 2025, its third straight year above 20%.Intuitive Surgical plans 11-15% higher 2026 operating expenses, boosting R&D and new platform investment.ISRG is expanding teams and shifting to direct Europe ops, adding costs but deepening market control.After an impressive 2025, Intuitive Surgical (ISRG) remains focused on sustaining earnings strength while investing aggressively in its future. The company posted 22% pro forma earnings per share (EPS) growth ...